Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AR101 Trial in Europe Measuring Oral Immunotherapy Success in Peanut Allergic Children (ARTEMIS)

NCT03201003 is registered in ClinicalTrials.gov with Aimmune Therapeutics, Inc. as lead sponsor.

NCT NCT03201003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03201003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AR101 Trial in Europe Measuring Oral Immunotherapy Success in Peanut Allergic Children (ARTEMIS)
Lead sponsor
Aimmune Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 12, 2017
Completion date
February 15, 2019
Enrollment
175 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy